Results 51 to 60 of about 47,291 (279)
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions [PDF]
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work ...
Buxton, Martin J +15 more
core +6 more sources
Abstract Objective Dietary therapy is an effective treatment for drug‐resistant epilepsy; however, low adherence presents a significant barrier to use in the clinical setting. This study aims to evaluate a multimodality digital health intervention to overcome this barrier and improve outcomes in adults undertaking the modified ketogenic diet for ...
Neha Kaul +18 more
wiley +1 more source
Background: Obesity is one of the most chronic disorders in childhood and its prevalence continues to increase rapidly. Although there is a growing awareness of the long-term health implications of obesity in children and adolescents, the more ...
Barbara Pacelli +2 more
core +1 more source
DOES CARDIAC REHABILITATON IMPROVE HEALTH RELATED QUALITY OF LIFE?
Backgrounds: The integration of EQ-5D questionnaire in the standard core set of utilized outcome measures may be useful aiming at a whole evaluation of cardiac rehabilitation improvements.
A. Mattivi +5 more
core +1 more source
Background The EuroQol Group recently developed two new instruments, the EQ Health and Wellbeing (EQ-HWB) and the EQ Health and Wellbeing short version (EQ-HWB-S).
Sara Masutti +5 more
doaj +1 more source
Background: Cost-effectiveness analysis using quality-adjusted life-years as the measure of health benefit is commonly used to aid decision-makers. Clinical studies often do not include preference-based measures that allow the calculation of quality ...
Mónica Hernández Alava +4 more
doaj +1 more source
Abstract Objective Post‐stroke epilepsy (PSE) affects ≈10% of patients with stroke and is associated with adverse health and economic outcomes. We aimed to review published literature on health and economic outcomes for patients with PSE, with a specific focus on quality of life, hospital readmissions, healthcare costs, seizure recurrence, and ...
Nega Dagnew Baye +5 more
wiley +1 more source
Patient Journey, Disease Burden, Treatment Patterns, and the Impact of Delayed Diagnosis Among Patients With Sjögren's Disease: A Real-World US Survey. [PDF]
Objective The aim of this study was to investigate disease burden, treatment patterns, and impact of delayed diagnosis on patient outcomes in Sjögren's disease (SjD) in a real‐world setting in the United States. Methods Data were drawn from the Adelphi Primary Sjögren's Syndrome Disease Specific Programme, a US‐based cross‐sectional collaborative ...
Lalla A +4 more
europepmc +2 more sources
This study developed a multifaceted intervention to strengthen primary care for cardiovascular risk management by leveraging both primary care and county hospitals in rural China. The purpose of this multicentre, cluster‐randomized controlled trial is to evaluate the effectiveness of intervention on the prevention of cardiovascular risks among patients
Weijia Lu +6 more
wiley +1 more source

